Research graph
References from Replication-Competent Herpes Simplex Virus Vector G207 and Cisplatin Combination Therapy for Head and Neck Squamous Cell Carcinoma. Local targets link to admitted publications; unresolved targets remain external evidence.
Cancer statistics, 1997
10.3322/canjclin.47.1.5 · 1997 · External reference
Head And Neck Tumor Cell Lines
1994 · External reference
Chemotherapy in head and neck cancer
10.1056/nejm198301133080204 · 1983 · External reference
The role of cisplatin in treatment regimens for squamous cell carcinoma of the head and neck
1991 · External reference
Induction chemotherapy plus radiation compared with surgery plus radiation in patients with advanced laryngeal cancer
1991 · External reference
Induction chemotherapy in advanced squamous head and neck carcinoma with high-dose cisplatinum and bleomycin infusion
10.1002/1097-0142(197907)44:1<19::aid-cncr2820440104>3.0.co;2-r · 1979 · External reference
Cisplatin and 5 fluorouracil infusion in patients with recurrent and disseminated epidermoid cancer of the head and neck
10.1002/1097-0142(19840501)53:9<1819::aid-cncr2820530903>3.0.co;2-r · 1984 · External reference
A phase III randomized study comparing cisplatin and fluorouracil as single agents and in combination for advanced squamous cell carcinoma of the head and neck
10.1200/jco.1992.10.2.257 · 1992 · External reference
Randomized study of preoperative versus postoperative radiation therapy in advanced head and neck carcinoma: Long-term follow-up of RTOG Study 73-03
10.1016/0360-3016(91)90133-o · 1991 · External reference
Metastatic patterns in squamous cell cancer of the head and neck
10.1016/0002-9610(89)90020-2 · 1987 · External reference
Re-irradiation with concomitant chemotherapy of unresectable recurrent head and neck cancer: a potentially curable disease
10.1093/oxfordjournals.annonc.a010793 · 1996 · External reference
Attenuated multi-mutated herpes simplex virus-1 for the treatment of malignant gliomas
10.1038/nm0995-938 · 1995 · External reference
Treatment of human malignant meningiomas by G207, a replication-competent multimutated herpes simplex virus 1
1995 · External reference
Treatment of human breast cancer in a brain metastatic model by G207, a replication-competent multimutated herpes simplex virus 1
10.1089/hum.1998.9.15-2177 · 1998 · External reference
A phase III randomised trial of cisplatinum, methotrextate, cisplatinum + methotrexate and cisplatinum + 5-FU in end stage squamous carcinoma of the head and neck
10.1038/bjc.1990.59 · 1990 · External reference
Experimental therapeutic approaches for recurrent head and neck cancer
10.1007/978-1-4615-2023-8_14 · 1995 · External reference
Chemotherapy for head and neck cancer
1986 · External reference
Long-term survival of rats harboring brain neoplasms treated with ganciclovir and a herpes simplex virus vector that retains an intact thymidine kinase gene
1994 · External reference
Defective herpes simplex virus vectors expressing thymidine kinase for the treatment of malignant glioma
1997 · External reference
An oncolytic viral mutant that delivers the CYP2B1 transgene and augments cyclophosphamide chemotherapy
10.1038/nbt0598-444 · 1998 · External reference
A novel three pronged approach to kill cancer cells selectively: concomitant viral, double suicide gene, and radiotherapy
10.1089/hum.1998.9.9-1323 · 1998 · External reference
ONYX-015, an E1B gene-attenuated adenovirus, causes tumor-specific cytolysis and antitumoral efficacy that can be augmented by standard chemotherapeutic agents
10.1038/nm0697-639 · 1997 · External reference
In situ cancer vaccination: an IL-12 defective vector/ replication-competent herpes simplex virus vector combination induces local and systemic antitumor activity
10.4049/jimmunol.160.9.4457 · 1998 · External reference
Treatment of intracranial gliomas in immunocompetent mice using herpes simplex viruses that express murine interleukins
10.1038/sj.gt.3300550 · 1998 · External reference
Enhancement of replication of genetically engineered herpes simplex viruses by ionizing radiation: a new paradigm for destruction of therapeutically intractable tumors
10.1038/sj.gt.3300546 · 1998 · External reference
Adenovirusmediated p53 gene therapy and paclitaxel have synergistic efficacy in models of human head and neck, ovarian, prostate, and breast cancer
1998 · External reference
A newly developed adenovirus-mediated transfer of a wild-type p53 gene increases sensitivity to cis-diamminedichloroplatinum (II) in p53-deleted ovarian cancer cells
10.1016/s0959-8049(98)00199-3 · 1998 · External reference
Characterization of a human squamous carcinoma cell line resistant to cis-diamminedichloroplatinum (II)
1987 · External reference
Antitumor activity of cis-diamminedichloroplatinum (II)against human tumor xenografts depends on its area under the curve in nude mice
10.1002/(sici)1096-9098(199602)61:2<138::aid-jso9>3.0.co;2-d · 1996 · External reference
Glutathione content but not gamma glutamylcysteine synthase mRNA expression predicts cisplatin resistance in head and neck cancer cell lines
10.1007/s002800050629 · 1997 · External reference
Head and Neck Cancer
10.1056/nejm199301213280306 · 1993 · External reference
Survival analysis of 5595 head and neck cancers-results of conventional treatment in a high-risk population
10.1038/bjc.1998.249 · 1998 · External reference
An HSVtk-mediated local and distant antitumor bystander effect in tumors of head and neck origin in athymic mice
1997 · External reference
HSV-tk gene therapy in head and neck squamous cell carcinoma
10.1001/archotol.1996.01890190042011 · 1996 · External reference
Increased survival with surgery alone vs
10.1288/00005537-197904000-00007 · 1979 · External reference
The efficacy of combining radiation therapy with a surgical procedure in patients with cervical metastasis from squamous cancer of the oropharynx and hypopharynx
10.1002/1097-0142(197504)35:4<1163::aid-cncr2820350422>3.0.co;2-c · 1975 · External reference
Binding of the antitumor drug cis-diamminedichloroplatinum(II) (cisplatin) to DNA
1985 · External reference
Sequence-dependent termination of in vitro DNA synthesis by cis- and trans-diamminedichloroplatinum (II)
10.1073/pnas.82.14.4616 · 1985 · External reference
Effect of the antitumor drug cis-diamminedichloroplatinum(II) and related platinum complexes on eukaryotic DNA replication
10.1021/bi00488a037 · 1990 · External reference
Enhanced replicative bypass of platinum-DNA adducts in cisplatin-resistant human ovarian carcinoma cell lines
1994 · External reference
The in-vitro and in-vivo efficacy of cisplatin and analogues in the treatment of herpes simplex virus-II infections
10.1093/jac/19.6.815 · 1987 · External reference
Herpes simplex virus type-1 single-strand DNA-binding protein (ICP8) enhances the ability of the viral DNA helicase-primase to unwind cisplatin-modified DNA
10.1074/jbc.273.22.13801 · 1998 · External reference
